Visualitzant Facultat de Ciències de la Salut Blanquerna per matèria "Infants autistes"

Ara mostrant els elements 1-2 de 2

    • CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders 

      Hernández Hernández, Marta; Bote, Valentin; Serra-Llovich, Alexandre; Cendros, Marc; Salazar, Juliana; Mestres Miralles, Concepción; Guijarro, Silvina; Alvarez, Aida; Lamborena, Cristina; Mendez, Iria; Sánchez, Bernardo; Hervas, Amaia; Arranz, Maria J (Pharmacogenomics and personalized medicine, 2022, vol. 15, p. 951-957, 2022-11)
      Purpose Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...

    • Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers 

      Arranz, Maria J; Salazar, Juliana; Bote, Valentin; Artigas-Baleri, Alícia; Serra-Llovich, Alexandre; Triviño, Emma; Roige, Jordi; Lombardia, Carlos; Cancino, Martha; Hernández Hernández, Marta; Cendros, Marc; Duran-Tauleria, Enric; Maraver, Natalia; Hervas, Amaia (Pharmaceutics, 2022, 14 (5), 999, 2022-05)
      BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...